Quotient Sciences Email Format
Pharmaceutical ManufacturingEngland, United Kingdom501-1000 Employees
Quotient Sciences operates as a drug development and manufacturing accelerator within the pharmaceutical sector, delivering integrated programs and tailored services that span the full development pathway. By coordinating activities across different development capabilities, the company aims to shorten timelines and reduce costs for customers seeking to bring medicines to patients. It is based in Nottingham, England, and maintains manufacturing and clinical facilities in the United States and the United Kingdom. The organization emphasizes a collaborative, continuous-improvement culture and describes itself as a partner for transforming ideas into solutions and medicines into therapies for patients in need. In 2026, Quotient Sciences announced an extended commercial supply partnership with Ipsen to manufacture a treatment for Fibrodysplasia Ossificans Progressiva, illustrating its active role in client collaborations across development and manufacturing.